IRVINE, CA, Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received CE Mark in Europe for its EDWARDS ...

Edwards Lifesciences Corp.’s traditional heart valves and critical-care products remain a steady beat of a company that’s seen a highly touted new device grab the spotlight. Investor and analyst ...

Irvine heart valve maker Edwards Lifesciences Corp. will start another domestic clinical trial in the months ahead. The Food and Drug Administration gave the company a conditional exemption to allow a ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, outcomes were similar among patients who had undergone transcatheter aortic-valve ...

Compared with traditional replacement valves, sutureless valves placed through minimally invasive cardiac surgery have less data supporting their use but offer unique features that might make them the ...

If you have aortic stenosis and a doctor deems your condition severe, you likely will need to have your valve replaced. You may be offered a transcatheter aortic valve replacement, or TAVR, or a ...